{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T08:21:57Z","timestamp":1785831717319,"version":"3.56.0"},"reference-count":26,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            This is a retrospective study of 15 difficult-to-treat (i.e., exhibiting previous failure, patient side effects, or resistance to ciprofloxacin and co-trimoxazole) chronic bacterial prostatitis infections (5 patients with multidrug-resistant\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Enterobacteriaceae<\/jats:named-content>\n            [MDRE]) receiving fosfomycin-tromethamine at a dose of 3 g per 48 to 72 h for 6 weeks. After a median follow-up of 20 months, 7 patients (47%) had a clinical response, and 8 patients (53%) had persistent microbiological eradication; 4\/5 patients with MDRE isolates achieved eradication. There were no side effects. Fosfomycin-tromethamine is a possible alternative therapy for chronic bacterial prostatitis.\n          <\/jats:p>","DOI":"10.1128\/aac.02611-15","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T04:43:50Z","timestamp":1450154630000},"page":"1854-1858","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":43,"title":["Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis"],"prefix":"10.1128","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8835-2702","authenticated-orcid":false,"given":"Ibai","family":"Los-Arcos","sequence":"first","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Pigrau","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Spanish Network for the Research in Infectious Diseases (REIPI RD12\/0015), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolors","family":"Rodr\u00edguez-Pardo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Spanish Network for the Research in Infectious Diseases (REIPI RD12\/0015), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Fern\u00e1ndez-Hidalgo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Spanish Network for the Research in Infectious Diseases (REIPI RD12\/0015), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Andreu","sequence":"additional","affiliation":[{"name":"Microbiology Department, Hospital Universitari Vall d'Hebron, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Spanish Network for the Research in Infectious Diseases (REIPI RD12\/0015), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Larrosa","sequence":"additional","affiliation":[{"name":"Microbiology Department, Hospital Universitari Vall d'Hebron, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Spanish Network for the Research in Infectious Diseases (REIPI RD12\/0015), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benito","family":"Almirante","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Spanish Network for the Research in Infectious Diseases (REIPI RD12\/0015), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/652861"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/aja.2008.46"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009071.pub2"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.03.014"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12275-011-0391-z"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2010.02.042"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70325-1"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.17.1897"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.08.039"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2010.22.5.355"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit704"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ436"},{"key":"e_1_3_2_14_2","volume-title":"Eficacia de la administraci\u00f3n de una pauta de fosfomicina-trometamol como terapia de rescate en pacientes con prostatitis cr\u00f3nica bacteriana (PCB), poster no. 838","author":"Los Arcos I","year":"2015","unstructured":"Los Arcos I, Pigrau C, Fern\u00e1ndez-Hidalgo N, Rodr\u00edguez-Pardo D, Andreu A, Almirante B. 2015. Eficacia de la administraci\u00f3n de una pauta de fosfomicina-trometamol como terapia de rescate en pacientes con prostatitis cr\u00f3nica bacteriana (PCB), poster no. 838. XIX Congreso de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC), 28 to 30 May 2015, Seville, Spain."},{"key":"e_1_3_2_15_2","first-page":"467","volume-title":"Infectious diseases","author":"Meares EM","year":"1972","unstructured":"Meares EM, Stamey TA. 1972. Bacterial prostatitis and recurrent urinary tract infections, p 467\u2013473. In Hoeprich PD (ed), Infectious diseases, 3rd ed. Harper & Row, Hagerstown, MD.","edition":"3"},{"key":"e_1_3_2_16_2","volume-title":"CLSI document M100-S24","author":"Clinical and Laboratory Standards Institute","year":"2014","unstructured":"Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI document M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ443"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.12.019"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-013-1055-x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-013-1145-9"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2010.00659.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0143-y"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019048-200009090-00004"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00536-1"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365590600748247"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-55382008000100006"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02611-15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02611-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T20:43:50Z","timestamp":1645476230000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02611-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1128\/AAC.02611-15"],"URL":"https:\/\/doi.org\/10.1128\/aac.02611-15","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"2015-10-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-02-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}